Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of SHR0410 injection for postoperative analgesia after laparoscopic surgery under general anesthesia
CTR20221638Phase 3Active
- Sponsor
- Hengrui Therapeutics
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of SHR0410 in postoperative pain, sponsored by Hengrui Therapeutics. Started Jul 2022; status: active.
02
Drugs
SHR0410
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20221638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221638.